Back to search
Diffuse Astrocytoma, IDH-Mutant
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Diffuse Astrocytoma, IDH-Mutant trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Diffuse Astrocytoma, IDH-Mutant trials you may qualify forProton therapy is a powerful tool enabling oncologists to spare normal tissue around the target for irradiation much better than what can be achieved with photo…
This multi-site, Phase 1/2 clinical trial is an open-label study to identify the safety, pharmacokinetics, and efficacy of a repeated dose regimen of NEO212 alo…
The researchers are doing this study to find out whether the radiopharmaceutical therapy (RPT) 177Lu-PSMA-617 is a safe treatment for people with IDH wild type…
This randomized phase II clinical trial studies the side effects and how well proton beam or intensity-modulated radiation therapy works in preserving brain fun…
This phase II trial studies the effect of immunotherapy drugs (ipilimumab and nivolumab) in treating patients with glioma that has come back (recurrent) and car…